-
-
Call more information
660-596-2224 -
On January 13, 2016, ASA and the American Society of Regional Anesthesia and Pain Medicine (ASRA) submitted formal recommendations to the Centers for Disease Control and Prevention (CDC) offering support for the proposed 2016 Guideline for Prescribing Opioids for Chronic Pain while expressing caution on its impact on therapies used to treat acute and chronic pain. The Guideline […]
Read MoreThe US Food and Drug Administration (FDA) has approved the Algovita Spinal Cord Stimulation System (Greatbatch Inc), a device to treat chronic pain, the company announced in a press release. The device is indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with […]
Read MoreNew American Academy of Pediatrics (AAP) guidelines, published November 30 in Pediatrics, identify key components for the pediatric perioperative anesthesia environment to optimize anesthetic care and reduce adverse events. “[T]he pediatric perioperative anesthesia environment is defined as areas of a patient care facility in which the patient preparation for, performance of, and recovery from surgical procedures occur […]
Read MoreAnesthesia & Analgesia: January 2016 – Volume 122 – Issue 1 – p 173–185 Egal, Mohamud MD et al BACKGROUND: We investigated whether resuscitation protocols to achieve and maintain urine output above a predefined threshold—including oliguria reversal as a target––prevent acute renal failure (ARF). METHODS: We performed a systematic review and meta-analysis using studies found […]
Read MoreAnesthesia & Analgesia: October 26, 2015 Prin, Meghan MD et al BACKGROUND: Pruritus is a common side effect of intrathecal fentanyl or sufentanil that decreases patient satisfaction and may delay hospital discharge. There are conflicting reports about the efficacy of prophylactic ondansetron in reducing the incidence of pruritus. This meta-analysis aimed to assess the effect […]
Read More